Raffles Medical - Maybank Research 2024-02-26: Normalising Earnings

• Raffles Medical (SGX:BSL)'s 2H23 PATMI of S$30.3m (-63.8% y-o-y) was broadly in line with our and market expectations, which brought full-year earnings to S$90.2M (-37.1% y-o-y).
• Raffles Medical declared a final dividend of 2.4 cents, representing 49.4% of FY23 core earnings. See Raffles Medical's dividend dates,

Insurance arm reported higher loss ratio

• - Read this at SGinvestors.io -
• - Read this at SGinvestors.io -

China operations on right trajectory

• Read more at SGinvestors.io.

Above is an excerpt from a report by Maybank Research.
Clients of Maybank Securities may be the first to access the full PDF report @ https://www.maybanktrade.com.sg/.

Read also Maybank's most recent report:
2025-07-26 Raffles Medical - No Major Surprises.

Previous report by Maybank:
2025-04-23 Raffles Medical - Strong Immunity; Strategic Collaboration In Shanghai.

Price targets by other brokers at Raffles Medical Target Prices.

Listing of research reports at Raffles Medical Analyst Reports.

Relevant links:
Raffles Medical Share Price History,
Raffles Medical Announcements,
Raffles Medical Dividend Payout Dates & Corporate Actions,
Raffles Medical News